In non-small cell lung cancer (NSCLC), YTHDF1 was reported to promote cancer cell proliferation and tumor progression by regulating the translational efficiency of CDK2, CDK4, and cyclin D192. This evidence concerns the gene CDK4 and non-small cell lung carcinoma.